APA (7th ed.) Citation

JAHM, P., JF, H., PHA, Q., & A, S. (2026). The Premature Termination of the Phase III SALAMANDER Trial of REX-001, an Autologous Bone Marrow Cell Therapy, for Chronic Limb Ischemia in Diabetic Patients: Insights and Outcomes. Annals of vascular surgery, 130, 282. https://doi.org/10.1016/j.avsg.2026.04.044

Chicago Style (17th ed.) Citation

JAHM, Peeters, Hamming JF, Quax PHA, and Schepers A. "The Premature Termination of the Phase III SALAMANDER Trial of REX-001, an Autologous Bone Marrow Cell Therapy, for Chronic Limb Ischemia in Diabetic Patients: Insights and Outcomes." Annals of Vascular Surgery 130 (2026): 282. https://doi.org/10.1016/j.avsg.2026.04.044.

MLA (9th ed.) Citation

JAHM, Peeters, et al. "The Premature Termination of the Phase III SALAMANDER Trial of REX-001, an Autologous Bone Marrow Cell Therapy, for Chronic Limb Ischemia in Diabetic Patients: Insights and Outcomes." Annals of Vascular Surgery, vol. 130, 2026, p. 282, https://doi.org/10.1016/j.avsg.2026.04.044.